阿卡迪亞製藥公司
MX ˙ BMV ˙ US0042251084
SecurityMX:ACAD / ACADIA Pharmaceuticals Inc.
InstitutionFmr Llc
Latest Disclosed Ownership5,265,357 shares
Ownership 3.21%
Fmr Llc ownership in ACAD / ACADIA Pharmaceuticals Inc.

2024-02-09 - Fmr Llc has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 5,265,357 shares of ACADIA Pharmaceuticals Inc. (MX:ACAD). This represents 3.207 percent ownership of the company. In their previous filing dated 2023-02-09 , Fmr Llc had reported owning 9,334,613 shares, indicating a decrease of -43.59 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date		Effective
Date		Form Prev
Shares		 Latest
Shares		 ΔShares
(Percent)		 Ownership
(Percent)		 ΔOwnership
(Percent)
2024-02-09 2024-02-09 13G/A 9,334,613 5,265,357 -43.59 3.21 -44.36
2023-02-09 2023-02-09 13G/A 13,840,750 9,334,613 -32.56 5.76 -33.05
2022-02-09 2022-02-09 13G/A 19,472,913 13,840,750 -28.92 8.61 -29.71
2021-02-08 2021-02-08 13G/A 20,890,917 19,472,913 -6.79 12.25 -9.70
2020-02-07 2020-02-07 13G/A 21,543,893 20,890,917 -3.03 13.56 -9.57
2019-02-13 2019-02-13 13G/A 18,630,845 21,543,893 15.64 15.00 0.00
2018-02-13 2018-02-13 13G/A 18,167,076 18,630,845 2.55 15.00 0.00
2017-02-14 2017-02-14 13G/A 15,136,743 18,167,076 20.02 15.00 0.00
2016-02-12 2016-02-12 13G/A 15,136,743 15.00
2015-02-13 2015-02-13 13G/A 14,965,545 15.00
2014-02-14 2014-02-14 13G/A 13,577,670 14.94
2013-01-10 2013-01-10 13G/A 9,652,910 12.77
2012-02-14 2012-02-14 13G/A 5,280,091 10.00

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 350,340 -376,623 -51.81 7,799 -59.84 0.0001
2026-02-17 2025-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 726,963 61,153 9.18 19,417 36.66 0.0010
2025-11-13 2025-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 665,810 496,448 293.13 14,208 288.94 0.0007
2025-08-14 2025-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 169,362 -4,889 -2.81 3,653 26.23 0.0002
2025-05-12 2025-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 174,251 36,226 26.25 2,894 14.30 0.0002
2025-02-13 2024-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 138,025 40,667 41.77 2,533 69.14 0.0002
2024-11-13 2024-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 97,358 -2,269,618 -95.89 1,497 -96.11 0.0001
2024-08-13 2024-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 2,366,976 -1,626,830 -40.73 38,463 -47.91 0.0025
2024-05-13 2024-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 3,993,806 -1,271,552 -24.15 73,845 -55.21 0.0050
2024-02-13 2023-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 5,265,358 -36,622 -0.69 164,858 49.20 0.0127
2023-11-13 2023-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 5,301,980 -19,257 -0.36 110,493 -13.30 0.0095
2023-08-11 2023-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 5,321,237 -2,525,436 -32.18 127,444 -13.70 0.0107
2023-08-11 2023-03-31 13F/A-1 ACADIA PHARMACEUTICALS COM 004225108 7,846,673 -1,487,941 -15.94 147,674 -0.63 0.0135
2023-05-11 2023-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 7,846,673 -1,487,941 147,674 0.0135
2023-02-13 2022-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 9,334,614 -2,236,411 -19.33 148,607 -21.50 0.0148
2022-11-10 2022-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 11,571,025 -827,932 -6.68 189,302 8.36 0.0197
2022-08-12 2022-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 12,398,957 -1,082,492 -8.03 174,701 -46.50 0.0174
2022-05-13 2022-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 13,481,449 -359,301 -2.60 326,520 1.08 0.0261
2022-02-14 2021-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 13,840,750 -2,035,794 -12.82 323,043 22.50 0.0239
2022-02-14 2021-09-30 13F/A-1 ACADIA PHARMACEUTICALS COM 004225108 15,876,544 377,406 2.44 263,710 -30.24 0.0209
2021-11-15 2021-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 15,876,544 377,406 263,710 0.0209
2021-08-13 2021-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 15,499,138 -1,688,345 -9.82 378,024 -14.75 0.0296
2021-05-14 2021-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 17,187,483 -2,285,431 -11.74 443,437 -57.40 0.0379
2021-02-08 2020-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 19,472,914 -275,434 -1.39 1,041,023 27.79 0.0926
2020-11-13 2020-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 19,748,348 -1,041,956 -5.01 814,619 -19.16 0.0823
2020-08-24 2020-06-30 13F/A-1 ACADIA PHARMACEUTICALS COM 004225108 20,790,304 499,407 2.46 1,007,706 17.55 0.1108
2020-08-13 2020-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 20,790,304 499,407 1,007,706 24,756.3875
2020-05-14 2020-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 20,290,897 -600,020 -2.87 857,291 -4.08 0.1187
2020-02-07 2019-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 20,890,917 -1,855,327 -8.16 893,714 9.17 0.0986
2019-11-13 2019-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 22,746,244 1,121,356 5.19 818,637 41.62 0.0982
2019-08-13 2019-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 21,624,888 42,531 0.20 578,033 -0.25 0.0675
2019-05-13 2019-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 21,582,357 38,464 0.18 579,486 66.34 0.0694
2019-02-13 2018-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 21,543,893 2,792,885 14.89 348,364 -10.51 0.0477
2018-11-09 2018-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 18,751,008 27,113 0.14 389,271 36.15 0.0438
2018-08-10 2018-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 18,723,895 18,604 0.10 285,914 -31.98 0.0338
2018-05-14 2018-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 18,705,291 74,446 0.40 420,308 -25.08 0.0499
2018-02-12 2017-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 18,630,845 270,800 1.47 560,974 -18.89 0.0658
2017-11-13 2017-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 18,360,045 53,079 0.29 691,623 35.46 0.0836
2017-08-29 2017-06-30 13F/A-1 ACADIA PHARMACEUTICALS COM 004225108 18,306,966 95,823 0.53 510,582 -18.45 0.0635
2017-08-11 2017-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 18,306,966 95,823 510,582
2017-05-11 2017-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 18,211,143 44,067 0.24 626,099 19.50 0.0795
2017-02-10 2016-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 18,167,076 68,724 0.38 523,938 -8.99 0.0700
2016-11-14 2016-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 18,098,352 1,128,901 6.65 575,708 4.52 0.0767
2016-08-11 2016-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 16,969,451 78,983 0.47 550,828 16.64 0.0752
2016-05-16 2016-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 16,890,468 1,753,725 11.59 472,257 -12.48 0.0653
2016-02-12 2015-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 15,136,743 29,516 0.20 539,625 8.01 0.0726
2015-11-10 2015-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 15,107,227 62,614 0.42 499,596 -20.71 0.0711
2015-08-25 2015-06-30 13F/A-1 ACADIA PHARMACEUTICALS COM 004225108 15,044,613 18,856 0.13 630,068 28.67 0.0807
2015-08-13 2015-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 15,044,613 630,068
2015-05-14 2015-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 15,025,757 60,212 0.40 489,689 3.06 0.0624
2015-02-17 2014-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 14,965,545 50,022 0.34 475,156 28.66 0.0618
2014-11-14 2014-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 14,915,523 72,075 0.49 369,308 10.14 0.0500
2014-08-14 2014-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 14,843,448 218,055 1.49 335,313 -5.77 0.0449
2014-05-15 2014-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 14,625,393 995,423 7.30 355,836 4.47 0.0494
2014-02-13 2013-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 13,629,970 301,805 2.26 340,613 -6.97 0.0481
2013-11-14 2013-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 13,328,165 73,430 0.55 366,124 52.19 0.0561
2013-09-24 2013-06-30 13F/A-1 ACADIA PHARMACEUTICALS COM 004225108 13,254,735 13,254,735 240,573 0.0394
2013-08-14 2013-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 13,254,735 240,573 0.0394
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.